NewYork-Presbyterian and content agency, Pace, received two awards for HealthMatters.nyp.org, the Hospital’s new digital storytelling platform. Health Matters won “Best Series of Articles” and “Best New Digital Publication - Design” at the Content Marketing Awards, the largest and longest-running international content marketing awards program in the world.

Scientific innovator and physician Dr. Pawel Muranski has joined NewYork-Presbyterian and Columbia University Medical Center (CUMC) as director of cellular immunotherapy at the newly established Good Manufacturing Practices (GMP) cell production lab and assistant director of Transfusion Medicine and Cellular Therapy. He will also serve on the faculty of CUMC as Assistant Professor of Medicine, Pathology and Cell Biology, a principal investigator at Columbia Center for Translational Immunology (CCTI) and a member of Columbia’s Herbert Irving Comprehensive Cancer Center

During excavation near Sixth Street and Eighth Avenue in Park Slope—the site for NewYork-Presbyterian Brooklyn Methodist Hospital’s new Center for Community Health (CCH)—about 30 large boulders were removed from the ground and donated to the Prospect Park Alliance. The Park plans to use these transplanted pieces of quartz granite for its Parks without Borders initiative.

With back-to-school quickly approaching, parents have already begun securing basic necessities like backpacks. Each year, millions of children return to school struggling under the weight of an overstuffed backpack. Heavy backpacks can put children at risk of injury, according to Dr. Joshua Hyman, orthopedic surgeon at NewYork-Presbyterian Morgan Stanley Children’s Hospital.

CIO Magazine has named NewYork-Presbyterian a 2017 CIO 100 Award winner. The 30th annual awards program honors and recognizes the cutting-edge innovations of companies that demonstrate excellence and achievement in information technology. The 2017 CIO 100 Awards were presented at the CIO 100 Symposium and Awards Ceremony on August 14 to 16, 2017 in Colorado Springs, Colorado.

Mendel Goldfinger, MD, and A. James D’Silva, MD, both specialists in the treatment of patients with cancer, recently joined NewYork-Presbyterian Brooklyn Methodist Hospital’s Division of Hematology/Oncology.

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research. Established in 2004, NIH Director’s Pioneer Awards, part of the NIH Common Fund, will provide nearly $1.2 million annually for five years to a single principal investigator who has demonstrated exceptional creativity and is pursuing a bold new research strategy against a major biomedical challenge.

NewYork-Presbyterian is deploying a Disaster Response Team to Puerto Rico today to help provide much-needed medical care for residents still suffering in the aftermath of Hurricane Maria. Our medical team includes four physicians and eight nurses with diverse areas of expertise.